UPDATE: Bank of America Reiterates on CareFusion Following ASHP Meeting

In a report published Wednesday, Bank of America analyst Bob Hopkins reiterated a Buy rating on CareFusion (NYSE: CFN ), and raised the price target from $43.00 to $45.00. In the report, Bank of America noted, “Last week we attended the American Society of Health-System Pharmacists (ASHP) meeting in Orlando,